Lumi Eyes (1x1ml) is an advanced eye booster formulated with high-purity polynucleotides (PDRN) to target under-eye concerns such as dark circles, fine lines, puffiness, and dermal thinning. Designed for intradermal administration in mesotherapy protocols, Lumi Eyes supports dermal regeneration and tissue repair without volumizing effects
Pricing is available to registered aesthetic professionals only.
Sign in to view pricesLumi Eyes is an injectable polynucleotide (PN/PDRN)-based medical aesthetic device specifically developed for periorbital skin rejuvenation. The product is designed to improve under-eye skin quality by targeting dermal thinning, dehydration, fine lines, dark circles, and fatigue-related changes without adding volume.
The formulation contains high-purity polynucleotides derived from DNA fragments, which act as biostimulatory agents within the dermis. When administered intradermally, Lumi Eyes supports fibroblast activation, extracellular matrix repair, improved microcirculation, and tissue hydration, making it suitable for patients presenting with fragile, crepey, or photo-aged under-eye skin.
Lumi Eyes is non-volumising and intended for regenerative skin improvement rather than contour correction or filling of the tear trough.
Lumi Eyes can be considered alongside other regenerative eye-area injectables such as Rejuran® i, Nucleofill® Eyes, or Sunekos® Performa, which aim to improve skin quality and biological function rather than volumisation.
Rejuran® i uses polynucleotides with a focus on dermal repair and anti-inflammatory activity.
Sunekos® combines amino acids and HA to stimulate collagen and elastin synthesis.
Lumi Eyes relies specifically on polynucleotide-driven tissue regeneration, hydration, and microvascular support.
Unlike traditional HA dermal fillers (e.g. Juvederm® or Restylane®), Lumi Eyes does not provide structural lift or bulk and should not be used as a tear-trough filler substitute. This comparison is for clinical orientation only and does not imply interchangeability.
According to distributor and manufacturer documentation, Lumi Eyes is indicated for the periorbital region, particularly where skin quality deterioration is present.
Primary indications:
Under-eye (infraorbital) area
Periorbital fine lines and superficial wrinkles
Thin, crepey, or lax under-eye skin
Dark circles related to poor microcirculation or dermal thinning
Fatigue-related under-eye appearance
Injection depth: Superficial to mid-dermal (intradermal mesotherapy technique)
Technique: Micro-papular or linear threading, depending on practitioner preference
Needle / cannula: Commonly 30–33 G needles (not always supplied)
Frequency / number of sessions:
Recommended course: 3 treatment sessions, spaced 3–4 weeks apart
Maintenance: Every 6–9 months, depending on patient response
Professional-use disclaimer: For administration by trained medical or aesthetic professionals only under aseptic conditions
If a specific parameter is not explicitly stated in the official IFU, it is considered “not provided by manufacturer”.
Active component:
Polynucleotides (PN / PDRN) – DNA fragments typically within the 250–350 kDa range, supporting tissue regeneration and dermal repair
Other components:
Sodium chloride
Phosphate buffer system
Water for injection
Lidocaine: Not provided by manufacturer
Cross-linking agents (e.g. BDDE): None
Presentation: 1 × 1 ml pre-filled sterile syringe
Lumi Eyes (1x1ml) format intended for precise periorbital treatment
Shelf-life: Refer to product packaging and IFU for expiry
Longevity (treatment duration):
Clinical reports suggest visible improvement lasting 6–12 months following a complete treatment course, depending on patient age, skin condition, and lifestyle factors.
Contraindicated in patients with known hypersensitivity to any component
Avoid use in areas with active infection, inflammation, or compromised skin
Not recommended during pregnancy or breastfeeding unless advised by local regulation
Do not inject intravascularly or into muscle tissue
Single-use product only; do not reuse syringe
CE-marked medical aesthetic device (classification dependent on jurisdiction)
Regulatory status may vary by country; practitioners should verify compliance via IFU and local distributor documentation
Lumi Eyes treatment works by delivering polynucleotides into the dermis of the under-eye area. These biologically active DNA fragments stimulate fibroblast activity, improve extracellular matrix repair, support hydration, and enhance microcirculation, resulting in improved skin texture, elasticity, and brightness.
No. Lumi Eyes is not a volumising filler. Unlike cross-linked HA fillers designed to lift or fill, Lumi Eyes focuses on regenerative skin improvement and is unsuitable for tear-trough volumisation.
A standard protocol includes three sessions spaced 3–4 weeks apart. Results typically last 6–12 months, depending on individual skin condition and maintenance strategy.
Yes. Lumi Eyes is commonly combined with microneedling, chemical peels, skin boosters, or polynucleotide-based facial treatments as part of a comprehensive regenerative protocol, provided appropriate timing and skin recovery are respected.
Due to the delicate vascular anatomy of the periorbital region, advanced anatomical knowledge and conservative technique are essential. Practitioners should avoid deep injections and monitor for swelling or bruising post-treatment.
Let’s talk on WhatsApp